Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 3Cohance Lifesciences
03 2Dr. Reddy's Laboratories
04 3Alfred E Tiefenbacher GmbH
05 1NanoAlvand
06 4Accord healthcare
07 1Actavis Inc
08 1Amneal Pharmaceuticals
09 1Arrotex Pharmaceuticals
10 2Aurobindo Pharma Limited
11 2Bayer AG
12 1Biocon
13 1CHEMO
14 1DelNova Healthcare
15 2Deva Holding AS
16 1Devatis AG
17 1Dr Reddy's Laboratories (Australia) Pty Ltd
18 2EG Spa
19 1ENDO OPERATIONS
20 1Farmatek
21 1Fresenius Kabi USA
22 1Fresenius SE & Co. KGaA
23 1GLAND PHARMA LIMITED
24 1Glenmark Pharmaceuticals
25 2Hainan Poly Pharm
26 3Health Biotech
27 1Hetero Drugs
28 1Hikma Pharmaceuticals
29 1Indoco Remedies Limited
30 1Inventia Healthcare Limited
31 1JAMP PHARMA
32 1Juno Pharmaceuticals Pty Ltd
33 1KMS Health Center
34 3MERCK CANADA INC
35 1MINT PHARMACEUTICALS INC
36 1MSD INTL GMBH
37 1Mallinckrodt Pharmaceuticals
38 17Merck & Co
39 1Pantson Pharma Pvt. Limited
40 1Pharmacore Inc
41 1Polifarma
42 4Sandoz B2B
43 1Sinotherapeutics
44 1Taro Pharmaceutical Industries
45 1Teva Pharmaceutical Industries
46 1Tillomed Laboratories Ltd
47 9Viatris
48 1WAGNER PHARMACEUTICALS PTY LTD
49 1Westminster Pharmaceutical
50 1Zentiva
51 1i3 Pharmaceuticals
01 1CONCENTRATE FOR SOLUTION FOR INFUSION
02 1Concentrate to the infusion fluid
03 1DR Tablet
04 1Delayed Release Pellet
05 2Delayed Release Tablet
06 1Enteric Coated Tablet
07 1Enteric Tablet
08 1FOR SUSPENSION, DELAYED RELEASE;ORAL
09 1Film Coated Tablet
10 4Filmtabl
11 1GASTRO
12 2Gastro Retentive Tablet
13 2Gastro-Resistant Tablet Oral Use Blister
14 5Gastro-Resistant Tablets
15 1Granules
16 1IV Solution for Infusion
17 1Inf Conc
18 3Injection
19 1ORAL SUSPENSION
20 1Oral Solid Dosage Form
21 8Oral Suspension
22 1Posaconazolo 100Mg 24 Units Of Oral Use
23 1Posaconazolo 40Mg/Ml 105Ml Oral Use
24 1Potion, suspension
25 1SOLUTION
26 6SOLUTION;INTRAVENOUS
27 1SUS
28 2SUSPENSION
29 1SUSPENSION; ORAL
30 2SUSPENSION;ORAL
31 5Susp
32 1Suspension
33 5TABLET (DELAYED-RELEASE)
34 12TABLET, DELAYED RELEASE;ORAL
35 6Tabl
36 2Tabl Gastro-Resistant
37 2Tablet
38 1Vial
39 6Blank
01 1Countries Registered In: Under Development for US & EU
02 2DISCN
03 4Generic
04 1Lead Market Dossiers- Filed
05 1Originator
06 19RX
07 2Status- Under Registration
08 66Blank
01 1GLN-POSACONAZOLE
02 1JAMP POSACONAZOLE
03 1MINT-POSACONAZOLE
04 6NOXAFIL
05 1NOXAFIL POWDERMIX KIT
06 13Noxafil
07 1Noxafil 40mg/ml
08 17POSACONAZOLE
09 1POSACONAZOLE ACCORD
10 1POSACONAZOLE DR.REDDY'S
11 1POSACONAZOLE EG STADA
12 1POSACONAZOLE FRESENIUS KABI
13 1POSACONAZOLE MYLAN
14 1POSACONAZOLE MYLAN PHARMA
15 1POSACONAZOLE STADA
16 1POSACONAZOLE TEVA
17 1POSACONAZOLE TILLOMED
18 1POSACONAZOLE ZENTIVA
19 1POSACONAZOLE-WGR
20 3POSANOL
21 1Pharmacor Posaconazole
22 1Pixana
23 1Posaconazole ARX
24 3Posaconazole Accord
25 1Posaconazole Devatis
26 1Posaconazole Juno
27 3Posaconazole Mylan
28 3Posaconazole Sandoz
29 3Posaconazole Viatris
30 2Posaconazole Zentiva
31 1SANDOZ POSACONAZOLE
32 1TARO-POSACONAZOLE
33 20Blank
01 6Australia
02 8Canada
03 2China
04 2Germany
05 12India
06 1Iran
07 13Italy
08 3Norway
09 1South Africa
10 1Spain
11 3Sweden
12 18Switzerland
13 4Turkey
14 22USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Posaconazole Zentiva
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-04-07
Application Number : 212500
Regulatory Info : RX
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2021-02-01
Application Number : 213454
Regulatory Info : RX
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Pixana
Dosage Form : Vial
Dosage Strength : 300MG/16.7ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Posaconazole Zentiva
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Granules
Dosage Strength : 16.39%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Delayed Release Pellet
Dosage Strength : 16.39%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-11-30
Application Number : 207355
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-12-22
Application Number : 216626
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 214842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2024-07-18
Application Number : 217119
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2006-09-15
Application Number : 22003
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SUSPENSION; ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number : 22027
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-02-04
Application Number : 214476
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 209983
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-12-08
Application Number : 214321
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2020-05-15
Application Number : 208773
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-08-28
Application Number : 216488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-05-10
Application Number : 212226
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-11-25
Application Number : 205053
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2014-03-13
Application Number : 205596
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL POWDERMIX KIT
Dosage Form : FOR SUSPENSION, DELAYED RELEASE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2021-05-31
Application Number : 214770
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-08-21
Application Number : 212411
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 211500
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-06-20
Application Number : 216326
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2022-05-25
Application Number : 208768
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
